Inhaled Tobramycin Effectively Reduces FEV(1) Decline in Cystic Fibrosis. An Instrumental Variables Analysis

Rationale: The efficacy of inhaled tobramycin on chronic Pseudomonas aeruginosa infections in patients with cystic fibrosis (CF) has been established in clinical trials. However, little is known about its clinical effectiveness on lung function outside randomized controlled trial settings; conventio...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Ann Am Thorac Soc
Autores principales: VanDyke, Rhonda D., McPhail, Gary L., Huang, Bin, Fenchel, Matthew C., Amin, Raouf S., Carle, Adam C., Chini, Barb A., Seid, Michael
Formato: Artigo
Lenguaje:Inglês
Publicado: American Thoracic Society 2013
Materias:
Original Research
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5475429/
https://ncbi.nlm.nih.gov/pubmed/23802816
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1513/AnnalsATS.201209-082OC
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares